PTCY-BASED HAPLOIDENTICAL TRANSPLANTATION, WITH REDUCED-DOSE MMF, 30 MG/KG, AND A CALCINEURIN INHIBITOR, COMPARED WITH ATG-BASED, 6 MG/KG, UNRELATED DONOR TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
Lido
514
Vezesque se leu este artigo
153
Total PDF
361
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 7 | 7 | 0 | 7 |
| 2025 6 | 47 | 21 | 68 |
| 2025 5 | 41 | 8 | 49 |
| 2025 4 | 34 | 9 | 43 |
| 2025 3 | 48 | 7 | 55 |
| 2025 2 | 36 | 22 | 58 |
| 2025 1 | 36 | 11 | 47 |
| 2024 12 | 35 | 11 | 46 |
| 2024 11 | 48 | 37 | 85 |
| 2024 10 | 29 | 27 | 56 |
